Annual Cash & Cash Equivalents
$606.10 M
+$39.80 M+7.03%
December 31, 2024
Summary
- As of February 26, 2025, DXCM annual cash & cash equivalents is $606.10 million, with the most recent change of +$39.80 million (+7.03%) on December 31, 2024.
- During the last 3 years, DXCM annual cash & cash equivalents has fallen by -$446.50 million (-42.42%).
- DXCM annual cash & cash equivalents is now -46.69% below its all-time high of $1.14 billion, reached on December 31, 2018.
Performance
DXCM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$606.10 M
-$15.10 M-2.43%
December 31, 2024
Summary
- As of February 26, 2025, DXCM quarterly cash and cash equivalents is $606.10 million, with the most recent change of -$15.10 million (-2.43%) on December 31, 2024.
- Over the past year, DXCM quarterly cash and cash equivalents has dropped by -$15.10 million (-2.43%).
- DXCM quarterly cash and cash equivalents is now -58.04% below its all-time high of $1.44 billion, reached on September 30, 2021.
Performance
DXCM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DXCM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.0% | -2.4% |
| 3 y3 years | -42.4% | -2.7% |
| 5 y5 years | +35.8% | -2.7% |
DXCM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.4% | +7.0% | -49.3% | +7.0% |
| 5 y | 5-year | -42.4% | +35.8% | -58.0% | +35.8% |
| alltime | all time | -46.7% | >+9999.0% | -58.0% | >+9999.0% |
DexCom Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $606.10 M(+7.0%) | $606.10 M(-2.4%) |
| Sep 2024 | - | $621.20 M(-33.9%) |
| Jun 2024 | - | $939.20 M(+10.3%) |
| Mar 2024 | - | $851.20 M(+50.3%) |
| Dec 2023 | $566.30 M(-11.8%) | $566.30 M(-12.0%) |
| Sep 2023 | - | $643.70 M(-46.1%) |
| Jun 2023 | - | $1.19 B(+91.7%) |
| Mar 2023 | - | $623.20 M(-3.0%) |
| Dec 2022 | $642.30 M(-39.0%) | $642.30 M(-8.0%) |
| Sep 2022 | - | $698.10 M(-5.1%) |
| Jun 2022 | - | $735.40 M(+2.7%) |
| Mar 2022 | - | $716.00 M(-32.0%) |
| Dec 2021 | $1.05 B(+28.7%) | $1.05 B(-27.1%) |
| Sep 2021 | - | $1.44 B(+24.6%) |
| Jun 2021 | - | $1.16 B(+57.9%) |
| Mar 2021 | - | $733.80 M(-10.2%) |
| Dec 2020 | $817.60 M(+83.2%) | $817.60 M(+21.4%) |
| Sep 2020 | - | $673.50 M(+27.1%) |
| Jun 2020 | - | $530.00 M(-9.3%) |
| Mar 2020 | - | $584.60 M(+31.0%) |
| Dec 2019 | $446.20 M(-60.8%) | $446.20 M(+12.8%) |
| Sep 2019 | - | $395.60 M(-44.2%) |
| Jun 2019 | - | $709.20 M(-44.8%) |
| Mar 2019 | - | $1.29 B(+13.0%) |
| Dec 2018 | $1.14 B(+157.5%) | $1.14 B(+209.5%) |
| Sep 2018 | - | $367.40 M(+22.4%) |
| Jun 2018 | - | $300.20 M(-28.6%) |
| Mar 2018 | - | $420.40 M(-4.8%) |
| Dec 2017 | $441.50 M(+367.2%) | $441.50 M(+9.8%) |
| Sep 2017 | - | $402.10 M(+1.6%) |
| Jun 2017 | - | $395.90 M(+157.9%) |
| Mar 2017 | - | $153.50 M(+62.4%) |
| Dec 2016 | $94.50 M(+9.8%) | $94.50 M(-3.3%) |
| Sep 2016 | - | $97.70 M(+11.7%) |
| Jun 2016 | - | $87.50 M(+12.3%) |
| Mar 2016 | - | $77.90 M(-9.5%) |
| Dec 2015 | $86.10 M(+19.9%) | $86.10 M(+0.9%) |
| Sep 2015 | - | $85.30 M(+26.0%) |
| Jun 2015 | - | $67.70 M(+24.9%) |
| Mar 2015 | - | $54.20 M(-24.5%) |
| Dec 2014 | $71.80 M | $71.80 M(+13.6%) |
| Sep 2014 | - | $63.20 M(+27.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $49.50 M(+8.3%) |
| Mar 2014 | - | $45.70 M(+5.8%) |
| Dec 2013 | $43.20 M(+433.3%) | $43.20 M(+29.3%) |
| Sep 2013 | - | $33.40 M(+18.4%) |
| Jun 2013 | - | $28.20 M(+49.2%) |
| Mar 2013 | - | $18.90 M(+133.3%) |
| Dec 2012 | $8.10 M(+211.5%) | $8.10 M(+70.7%) |
| Sep 2012 | - | $4.74 M(-20.7%) |
| Jun 2012 | - | $5.99 M(+16.9%) |
| Mar 2012 | - | $5.12 M(+96.9%) |
| Dec 2011 | $2.60 M(-46.8%) | $2.60 M(-85.2%) |
| Sep 2011 | - | $17.52 M(-48.3%) |
| Jun 2011 | - | $33.89 M(+790.6%) |
| Mar 2011 | - | $3.81 M(-22.2%) |
| Dec 2010 | $4.89 M(+36.7%) | $4.89 M(-11.6%) |
| Sep 2010 | - | $5.53 M(-9.2%) |
| Jun 2010 | - | $6.09 M(-43.1%) |
| Mar 2010 | - | $10.70 M(+199.1%) |
| Dec 2009 | $3.58 M(-71.8%) | $3.58 M(-43.8%) |
| Sep 2009 | - | $6.36 M(+51.2%) |
| Jun 2009 | - | $4.21 M(-54.6%) |
| Mar 2009 | - | $9.28 M(-27.0%) |
| Dec 2008 | $12.70 M(-45.1%) | $12.70 M(+173.6%) |
| Sep 2008 | - | $4.64 M(-6.5%) |
| Jun 2008 | - | $4.96 M(-79.3%) |
| Mar 2008 | - | $23.95 M(+3.6%) |
| Dec 2007 | $23.11 M(+27.2%) | $23.11 M(+52.3%) |
| Sep 2007 | - | $15.18 M(-41.4%) |
| Jun 2007 | - | $25.88 M(-53.6%) |
| Mar 2007 | - | $55.83 M(+207.3%) |
| Dec 2006 | $18.17 M(-51.2%) | $18.17 M(-21.7%) |
| Sep 2006 | - | $23.20 M(-3.2%) |
| Jun 2006 | - | $23.98 M(+18.8%) |
| Mar 2006 | - | $20.18 M(-45.8%) |
| Dec 2005 | $37.25 M(+36.8%) | $37.25 M(-11.6%) |
| Sep 2005 | - | $42.12 M(-18.2%) |
| Jun 2005 | - | $51.49 M(+1008.7%) |
| Mar 2005 | - | $4.64 M |
| Dec 2004 | $27.23 M(+36.0%) | - |
| Dec 2003 | $20.02 M(+157.4%) | - |
| Dec 2001 | $7.78 M(-44.0%) | - |
| Dec 2000 | $13.90 M | - |
FAQ
- What is DexCom annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for DexCom?
- What is DexCom annual cash & cash equivalents year-on-year change?
- What is DexCom quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for DexCom?
- What is DexCom quarterly cash and cash equivalents year-on-year change?
What is DexCom annual cash & cash equivalents?
The current annual cash & cash equivalents of DXCM is $606.10 M
What is the all time high annual cash & cash equivalents for DexCom?
DexCom all-time high annual cash & cash equivalents is $1.14 B
What is DexCom annual cash & cash equivalents year-on-year change?
Over the past year, DXCM annual cash & cash equivalents has changed by +$39.80 M (+7.03%)
What is DexCom quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DXCM is $606.10 M
What is the all time high quarterly cash and cash equivalents for DexCom?
DexCom all-time high quarterly cash and cash equivalents is $1.44 B
What is DexCom quarterly cash and cash equivalents year-on-year change?
Over the past year, DXCM quarterly cash and cash equivalents has changed by -$15.10 M (-2.43%)